APA (7th ed.) Citation

Y, L., T, T., R, L., N, S., N, S., AM, L., & P, B. (2025). Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis. Ocular immunology and inflammation, 1. https://doi.org/10.1080/09273948.2025.2504577

Chicago Style (17th ed.) Citation

Y, Li, Thongborisuth T, Lee R, Stolberg N, Sweiss N, Lobo-Chan AM, and Bhat P. "Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis." Ocular Immunology and Inflammation 2025: 1. https://doi.org/10.1080/09273948.2025.2504577.

MLA (9th ed.) Citation

Y, Li, et al. "Safety and Efficacy of High-Dosage Infliximab in Recalcitrant Retinal Vasculitis." Ocular Immunology and Inflammation, 2025, p. 1, https://doi.org/10.1080/09273948.2025.2504577.